A recent discovery of a molecular connection between autism and myotonic dystrophy, a type of neuromuscular disease, may provide a breakthrough on how clinicians approach autism spectrum disorder. The new study by an interdisciplinary team of biomedical scientists, published on April 21 in Nature Neuroscience, used myotonic dystrophy as a tool or model to learn more about autism – effectively using one disorder to better understand the other.

In December 2020, Ben Strahan thought he’d lost the will to live. It had been a long, isolating year for the Reno-based wildland firefighter. The COVID pandemic was still in full swing, and that year’s fire season had been extreme.

In December 2020, Ben Strahan thought he’d lost the will to live. It had been a long, isolating year for the Reno-based wildland firefighter. The COVID pandemic was still in full swing, and that year’s fire season had been extreme.

The US Drug Enforcement Administration (DEA) plans to reclassify marijuana to a Schedule III controlled substance from Schedule I. This shift would not only recognize the drug’s medicinal uses, but also acknowledge that it has less potential for abuse.

While most psychedelic drugs remain illegal, that could change as their health benefits become more widely known both in the United States and Nevada, where further psychedelic-assisted therapy could be on the horizon.

John Dalton, a retired Navy SEAL, lost nine of his fellow SEALs in the last year — all to suicide or alcoholism induced by PTSD and traumatic brain injuries. 

An estimated 11% of adults in the US said in a 2021 survey they had taken psilocybin or mushrooms. But not everyone makes "magic mushrooms" a family affair.

Neuroscientists explain how developing brains may be vulnerable to psilocybin's negative effects.